Eiko Lifesciences share news, announcements and annual reports
BSE: 540204Chemicals & PetrochemicalsSmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹51.52.
30 Oct: open ₹52.64, high ₹52.93, low ₹50.27
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹74 Cr3,149th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.08
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 9.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.07
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,609
Eiko Lifesciences share news and announcements
531 announcements, routine notices left out, newest first. Page 3 of 11.
Oct 2024
11 Oct · Board meeting
Meeting on 19 Oct 2024: quarterly results8 Oct · Updates on Open Offer
7 Oct · Updates on Open Offer
Sep 2024
30 Sep · Meeting
30 Sep · Announcement under Regulation 30 (LODR)-Retirement
30 Sep · Letter of Offer
28 Sep · Meeting
5 Sep · Meeting
5 Sep · Meeting
3 Sep · Management
3 Sep · Management
3 Sep · Management
3 Sep · Management
3 Sep · Board meeting
Aug 2024
13 Aug · Business
13 Aug · Board meeting
5 Aug · Board meeting
Meeting on 13 Aug 2024: quarterly results
Jul 2024
24 Jul · Draft Letter of Offer
10 Jul · Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer
10 Jul · Public Announcement - Open Offer (Revised)
10 Jul · Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer
May 2024
30 May · Incorporation Of Limited Liability Partnership
13 May · Management
13 May · Management
13 May · Results
6 May · Board meeting
Meeting on 13 May 2024: audited results
Apr 2024
19 Apr · Business
17 Apr · Certificate Under Regulation 40(9) Of SEBI (Listing Obligations & Disclosure Requirements ) Regulations, 2015
17 Apr · Compliance Certificate Under Regulation 7(3) Of Securities Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulation 2015 For The Financial Year Ended 31St March, 2024
Mar 2024
19 Mar · Announcement under Regulation 30 (LODR)-Allotment
Feb 2024
8 Feb · Board meeting
2 Feb · Submission Of Revised Corporate Announcement As Per BSE E-Mail Dated 02Nd February, 2024
1 Feb · Intimation Of Right Issue Committee Meeting Of The Board Of Directors To Be Held On 08Th February,2024